$SPRO
Spero Therapeutics Inc

2018 Q4 Form 10-K Financial Statement

#000156459019007805 Filed on March 14, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q2 2017 Q4
Revenue $1.692M $463.0K $993.0K
YoY Change 70.39% 85.94% 196.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.650M $3.060M $2.490M
YoY Change 46.59% 3.38% 12.16%
% of Gross Profit
Research & Development $9.130M $7.374M $12.50M
YoY Change -26.96% -1.11% 80.38%
% of Gross Profit
Depreciation & Amortization $140.0K $90.00K $100.0K
YoY Change 40.0% 12.5% 11.11%
% of Gross Profit
Operating Expenses $12.78M $10.43M $14.99M
YoY Change -14.79% 0.19% 63.95%
Operating Profit -$9.971M
YoY Change -1.91%
Interest Expense $0.00 $15.00K -$10.00K
YoY Change -100.0% -71.15% -101.61%
% of Operating Profit
Other Income/Expense, Net $490.0K $15.00K $140.0K
YoY Change 250.0% -96.27%
Pretax Income -$10.60M -$9.960M -$13.87M
YoY Change -23.58% 2.05% 69.15%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$10.60M -$9.956M -$13.86M
YoY Change -23.54% 8.58% 92.23%
Net Earnings / Revenue -626.42% -2150.32% -1395.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$596.8K -$692.6K -$964.5K
COMMON SHARES
Basic Shares Outstanding 18.19M 14.37M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q2 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.4M $66.60M $87.30M
YoY Change 32.19% 83.47%
Cash & Equivalents $34.08M $48.72M $87.29M
Short-Term Investments $81.40M $17.90M
Other Short-Term Assets $7.500M $1.200M $1.800M
YoY Change 316.67% 33.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $124.2M $70.50M $92.06M
YoY Change 34.93% 88.0% 675.43%
LONG-TERM ASSETS
Property, Plant & Equipment $2.893M $1.000M $1.164M
YoY Change 148.54% -23.08% -22.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.661M $700.0K $300.0K
YoY Change 453.67% 40.0%
Total Long-Term Assets $4.787M $2.100M $1.420M
YoY Change 237.11% -19.23% -25.26%
TOTAL ASSETS
Total Short-Term Assets $124.2M $70.50M $92.06M
Total Long-Term Assets $4.787M $2.100M $1.420M
Total Assets $129.0M $72.60M $93.48M
YoY Change 38.01% 81.05% 578.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.603M $700.0K $3.470M
YoY Change 3.83% -50.0% 204.65%
Accrued Expenses $8.300M $5.500M $4.300M
YoY Change 93.02% 17.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.32M $6.600M $8.157M
YoY Change 51.01% 3.13% 17.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $800.0K $300.0K $400.0K
YoY Change 100.0% -25.0%
Total Long-Term Liabilities $800.0K $300.0K $400.0K
YoY Change 100.0% -25.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.32M $6.600M $8.157M
Total Long-Term Liabilities $800.0K $300.0K $400.0K
Total Liabilities $13.15M $7.300M $8.522M
YoY Change 54.32% -12.05% 14.99%
SHAREHOLDERS EQUITY
Retained Earnings -$138.5M -$96.84M
YoY Change 43.02% 113.12%
Common Stock $254.0M $14.00K
YoY Change 1814400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $115.5M $65.30M $84.60M
YoY Change
Total Liabilities & Shareholders Equity $129.0M $72.60M $93.48M
YoY Change 38.01% 81.05% 578.76%

Cashflow Statement

Concept 2018 Q4 2018 Q2 2017 Q4
OPERATING ACTIVITIES
Net Income -$10.60M -$9.956M -$13.86M
YoY Change -23.54% 8.58% 92.23%
Depreciation, Depletion And Amortization $140.0K $90.00K $100.0K
YoY Change 40.0% 12.5% 11.11%
Cash From Operating Activities -$13.51M -$8.640M -$12.74M
YoY Change 6.04% -2.7% 38.48%
INVESTING ACTIVITIES
Capital Expenditures -$2.420M -$30.00K
YoY Change 7966.67% -88.46%
Acquisitions
YoY Change
Other Investing Activities $9.700M $5.000M
YoY Change
Cash From Investing Activities $7.280M $5.000M -$30.00K
YoY Change -24366.67% -88.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -180.0K -200.0K 74.68M
YoY Change -100.24% -82.76% 778.59%
NET CHANGE
Cash From Operating Activities -13.51M -8.640M -12.74M
Cash From Investing Activities 7.280M 5.000M -30.00K
Cash From Financing Activities -180.0K -200.0K 74.68M
Net Change In Cash -6.410M -3.840M 61.91M
YoY Change -110.35% -61.75% -6548.96%
FREE CASH FLOW
Cash From Operating Activities -$13.51M -$8.640M -$12.74M
Capital Expenditures -$2.420M -$30.00K
Free Cash Flow -$11.09M -$12.71M
YoY Change -12.75% 42.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2011296
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2642784
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1828000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3220
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3220
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34080000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87288000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
81363000
CY2018Q4 us-gaap Other Receivables
OtherReceivables
376000
CY2017Q4 us-gaap Other Receivables
OtherReceivables
1011000
CY2018Q4 spro Tax Incentive Receivable Current
TaxIncentiveReceivableCurrent
922000
CY2017Q4 spro Tax Incentive Receivable Current
TaxIncentiveReceivableCurrent
1932000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7478000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
254013000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181428000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138502000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
124219000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
92059000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2893000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1164000
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
153000
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
206000
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
316000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1192000
CY2018Q4 spro Tax Incentive Receivable Noncurrent
TaxIncentiveReceivableNoncurrent
233000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
50000
CY2018Q4 us-gaap Assets
Assets
129006000
CY2017Q4 us-gaap Assets
Assets
93479000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3603000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3470000
CY2018Q4 spro Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8263000
CY2017Q4 spro Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4321000
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
223000
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
223000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
229000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
143000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12318000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8157000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
833000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
365000
CY2018Q4 us-gaap Liabilities
Liabilities
13151000
CY2017Q4 us-gaap Liabilities
Liabilities
8522000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96840000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
115500000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
84602000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
355000
CY2017Q4 us-gaap Minority Interest
MinorityInterest
355000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
115855000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84957000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129006000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93479000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17205962
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14369182
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17205962
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14369182
CY2018 us-gaap Revenues
Revenues
3966000
CY2017 us-gaap Revenues
Revenues
1979000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7223000
CY2016 us-gaap Operating Expenses
OperatingExpenses
33556000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-33221000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
303000
CY2017 spro Accretion Of Redeemable Bridge Units And Redeemable Convertible Preferred Shares To Redemption Value
AccretionOfRedeemableBridgeUnitsAndRedeemableConvertiblePreferredSharesToRedemptionValue
1208000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46097000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41690000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39886000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-18553000
CY2016 spro Cumulative Dividends On Redeemable Convertible Preferred Units
CumulativeDividendsOnRedeemableConvertiblePreferredUnits
-3441000
CY2016 spro Stockholders Equity Accretion Of Redeemable Preferred Units To Redemption Value
StockholdersEquityAccretionOfRedeemablePreferredUnitsToRedemptionValue
969000
CY2016 spro Stockholders Equity Accretion Of Bridge Units To Redemption Value
StockholdersEquityAccretionOfBridgeUnitsToRedemptionValue
27000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
130175000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-49248000
CY2017 spro Stockholders Equity Accretion Of Bridge Units To Redemption Value
StockholdersEquityAccretionOfBridgeUnitsToRedemptionValue
576000
CY2017 spro Cumulative Dividends On Redeemable Convertible Preferred Units
CumulativeDividendsOnRedeemableConvertiblePreferredUnits
-3261000
CY2017 spro Stockholders Equity Accretion Of Redeemable Preferred Units To Redemption Value
StockholdersEquityAccretionOfRedeemablePreferredUnitsToRedemptionValue
369000
CY2017 spro Cumulative Dividends On Redeemable Convertible Preferred Shares
CumulativeDividendsOnRedeemableConvertiblePreferredShares
-2885000
CY2017 spro Stockholders Equity Accretion Of Preferred Stock To Redemption Value
StockholdersEquityAccretionOfPreferredStockToRedemptionValue
263000
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
107018000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1427000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
335000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2749000
CY2016 spro Issuance Of Stock For License
IssuanceOfStockForLicense
4595000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
409000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
363000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
279000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-248000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2749000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1427000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
180000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-373000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-83000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
671000
CY2018 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-635000
CY2017 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
707000
CY2016 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
294000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5497000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
575000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
966000
CY2018 spro Increase Decrease In Tax Incentives Receivable
IncreaseDecreaseInTaxIncentivesReceivable
-770000
CY2017 spro Increase Decrease In Tax Incentives Receivable
IncreaseDecreaseInTaxIncentivesReceivable
1811000
CY2016 spro Increase Decrease In Tax Incentives Receivable
IncreaseDecreaseInTaxIncentivesReceivable
144000
CY2016 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-53000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
84000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2349000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-644000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3575000
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1315000
CY2016 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2322000
CY2018 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
554000
CY2017 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-128000
CY2016 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-84000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1192000
CY2016 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-929000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39625000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39111000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28959000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
49455000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2436000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
830000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83156000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-830000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
335000
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
77749000
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3574000
CY2017 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1175000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34413000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69523000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
116111000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53258000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
76973000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4624000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87338000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10365000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5741000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34080000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000
CY2017 spro Conversion Of Bridge Units Into Preferred Units
ConversionOfBridgeUnitsIntoPreferredUnits
8500000
CY2017 spro Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
107018000
CY2017 spro Settlement Of Derivative Liability Upon Issuance Of Preferred Units
SettlementOfDerivativeLiabilityUponIssuanceOfPreferredUnits
944000
CY2016 spro Issuance Of Tranche Rights With Preferred Units
IssuanceOfTrancheRightsWithPreferredUnits
909000
CY2016 spro Deemed Contribution Of Capital
DeemedContributionOfCapital
2408000
CY2016 spro Settlement Of Derivative Liability Upon Issuance Of Bridge Units
SettlementOfDerivativeLiabilityUponIssuanceOfBridgeUnits
305000
CY2016 us-gaap Payments Of Derivative Issuance Costs
PaymentsOfDerivativeIssuanceCosts
908000
CY2017 spro Accretion Of Redeemable Convertible Preferred Units And Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredUnitsAndStockToRedemptionValue
632000
CY2016 spro Accretion Of Redeemable Convertible Preferred Units And Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredUnitsAndStockToRedemptionValue
969000
CY2017 spro Accretion Of Bridge Units To Redemption Value
AccretionOfBridgeUnitsToRedemptionValue
576000
CY2016 spro Accretion Of Bridge Units To Redemption Value
AccretionOfBridgeUnitsToRedemptionValue
27000
CY2016 spro Issuance Of Additional Shares Of Common Stock To Minority Investors Under Antidilutive Rights
IssuanceOfAdditionalSharesOfCommonStockToMinorityInvestorsUnderAntidilutiveRights
980000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual for research and development expenses, the valuation of common shares prior to the Company&#8217;s IPO, the valuation of share-based awards and the valuation of derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates, as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions. </p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and of Significant Suppliers </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains most of its cash and cash equivalents at one accredited financial institution. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is dependent on third-party manufacturers to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients and formulated drugs. </p>
CY2018 spro Entity Incorporation Month And Year
EntityIncorporationMonthAndYear
2013-12
CY2018 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2018 us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2017-06-30
CY2018 spro Business Combination Exchange Ratio
BusinessCombinationExchangeRatio
1
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5400000
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4200000
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.741
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.771
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.765
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-38706000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-27148000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1180000
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
81391000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
28000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
81363000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3720000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1807000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
827000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
643000
CY2017Q4 spro Accrued External Research And Development Expenses Current
AccruedExternalResearchAndDevelopmentExpensesCurrent
1770000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1369000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
878000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
304000
CY2017Q2 spro Convertible Preferred Shares To Common Shares Conversion Ratio
ConvertiblePreferredSharesToCommonSharesConversionRatio
1
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
61917986
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders.
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
21116
CY2016Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.001
CY2017Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
5.90
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5493000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-39886000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32641000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.033
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.017
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.053
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.044
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.023
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.048
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.238
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.188
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.330
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29025000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21754000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3385000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2022000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1731000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
743000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34141000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24519000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34141000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24519000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
100400000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
100300000
CY2018 spro Operating Loss Carryforward Federal And State Expiration Year Start
OperatingLossCarryforwardFederalAndStateExpirationYearStart
2033
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
11700000
CY2018 spro Ownership Change Increase In Ownership By Maximum Percentage
OwnershipChangeIncreaseInOwnershipByMaximumPercentage
0.50
CY2018 spro Ownership Change Increase In Ownership Percentage Term
OwnershipChangeIncreaseInOwnershipPercentageTerm
P3Y
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17152000
CY2018 spro Valuation Allowance Deferred Tax Asset Increase In Amount
ValuationAllowanceDeferredTaxAssetIncreaseInAmount
9622000
CY2017 spro Valuation Allowance Deferred Tax Asset Increase In Amount
ValuationAllowanceDeferredTaxAssetIncreaseInAmount
7367000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 spro Tax Cuts And Jobs Act Of2017 Net Operating Losses Limitation Percentage
TaxCutsAndJobsActOf2017NetOperatingLossesLimitationPercentage
0.80
CY2017 spro Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Decrease In Deferred Tax Asset
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDecreaseInDeferredTaxAsset
9400000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1361000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1054000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
995000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1107000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1123000
CY2018Q4 spro Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
1138000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1108000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7886000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5517810
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0
CY2016 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0
CY2018Q1 us-gaap Revenues
Revenues
1153000
CY2018Q2 us-gaap Revenues
Revenues
463000
CY2018Q3 us-gaap Revenues
Revenues
658000
CY2018Q4 us-gaap Revenues
Revenues
1692000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
11969000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
10434000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
11593000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
12776000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-10644000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-9956000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-10463000
CY2018Q4 us-gaap Profit Loss
ProfitLoss
-10599000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14369182
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14376529
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17471462
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17736996
CY2017Q1 us-gaap Revenues
Revenues
140000
CY2017Q2 us-gaap Revenues
Revenues
249000
CY2017Q3 us-gaap Revenues
Revenues
597000
CY2017Q4 us-gaap Revenues
Revenues
993000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
7739000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
10414000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
10563000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
14993000
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-6411000
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-9763000
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-9844000
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-13868000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-5876000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-9169000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-9836000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-13862000
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7130000
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12121000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12076000
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14770000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-21.60
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-36.21
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-36.02
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.59
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
330075
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
334788
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
335285
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9273783

Files In Submission

Name View Source Status
0001564590-19-007805-index-headers.html Edgar Link pending
0001564590-19-007805-index.html Edgar Link pending
0001564590-19-007805.txt Edgar Link pending
0001564590-19-007805-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0gp05pn1hgz000001.jpg Edgar Link pending
g0gp05pn1hgz000002.jpg Edgar Link pending
g0itfpndycnc000001.jpg Edgar Link pending
g0itfpndycnc000002.jpg Edgar Link pending
g0itfpndycnc000003.jpg Edgar Link pending
g0itfpndycnc000004.jpg Edgar Link pending
g0itfpndycnc000005.jpg Edgar Link pending
g0itfpndycnc000006.jpg Edgar Link pending
g0itfpndycnc000007.jpg Edgar Link pending
g0itfpndycnc000008.jpg Edgar Link pending
g0itfpndycnc000009.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spro-10k_20181231.htm Edgar Link pending
spro-20181231.xml Edgar Link completed
spro-20181231.xsd Edgar Link pending
spro-20181231_cal.xml Edgar Link unprocessable
spro-20181231_def.xml Edgar Link unprocessable
spro-20181231_lab.xml Edgar Link unprocessable
spro-20181231_pre.xml Edgar Link unprocessable
spro-ex1020_863.htm Edgar Link pending
spro-ex103_861.htm Edgar Link pending
spro-ex104_862.htm Edgar Link pending
spro-ex211_8.htm Edgar Link pending
spro-ex231_9.htm Edgar Link pending
spro-ex311_10.htm Edgar Link pending
spro-ex312_6.htm Edgar Link pending
spro-ex321_12.htm Edgar Link pending
spro-ex322_11.htm Edgar Link pending